Sen. Burr Releases New Report With Recommendations to Strengthen FDA's Regulatory Readiness
October 01, 2021
October 01, 2021
WASHINGTON, Oct. 1 -- Sen. Richard Burr, R-North Carolina, issued the following news release on Sept. 30, 2021:
Senator Richard Burr (R-NC), Ranking Member of the Senate Health, Education, Labor and Pensions (HELP) Committee, released a new report with recommendations for strengthening the U.S. Food and Drug Administration's (FDA) regulatory readiness, building on lessons learned from the pandemic to better prepare for the future.
"As we take stock of lessons . . .
Senator Richard Burr (R-NC), Ranking Member of the Senate Health, Education, Labor and Pensions (HELP) Committee, released a new report with recommendations for strengthening the U.S. Food and Drug Administration's (FDA) regulatory readiness, building on lessons learned from the pandemic to better prepare for the future.
"As we take stock of lessons . . .
